NASDAQ: FNCH - Finch Therapeutics Group, Inc.
Доходность за полгода: -42.74%
Сектор: Healthcare
| Параметр | Оценка | Значение | Среднее по сектору | Разница с сектором, % | Средняя за 5 лет | Разница со средней, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-0.1404 | 47.96 | -100.29% | 0 | 0% |
P/E Forward 
|
|
-0.2456 | 0 | 0% | ||
| P/S |
|
98.13 | 33.73 | 190.96% | 32.45 | 202.4% |
| P/S Forward |
|
65.14 | 32.45 | 100.75% | ||
| P/BV |
|
0.1479 | 4.81 | -96.92% | 0.8765 | -83.13% |
| P/BV Forward |
|
0.1946 | 0.8765 | -77.8% | ||
| Ev/Ebitda |
|
-0.3292 | -22.5 | -98.54% | 0.0358 | -1019.96% |
| Ev/Ebitda Forward |
|
0.473 | 0.0358 | 1221.56% |
